Sire Bioscience Inc. (CSE:SIRE, OTC:BLLXF, FSE:BR1B) (“Sire” or the “Company”) is pleased to announce that Brian Polla, the Company’s Founder and current COO and director, has been appointed as the new CEO of the Company, effective immediately.
Mr. Polla is a successful entrepreneur with over 20 years of business management experience and capital market expertise. Over the years, Mr. Polla has developed an extensive background in the health and wellness sector. As SIRE’s founding member, Mr. Polla has been working tirelessly behind the scenes to bring the Company’s vision to life. Upon stepping into the CEO role, his immediate focus will be on improving shareholder value.
“We are always pushing to accelerate our efforts to drive long-term, sustainable shareholder value,” says Mr. Polla, “one way that we will do this is through our ‘House of Brands’ strategy which will provide customized products for unique consumer experiences. We will also tap into our team’s extensive CPG background to create thriving brands.”
To facilitate the change in management, Jeff Zanini will be stepping down as the CEO and a director but will remain a strategic advisor to SIRE. The Company’s board of directors sincerely thanks him for his contribution and leadership, and wishes him the best in his future endeavours.
About Sire Bioscience
Sire’s principal business activity is to engage in the investment, production of, and sale of hemp. Its mission is to offer people a way to connect with themselves, with others, and with the world around them.
SIRE is headquartered in Toronto, Ontario and is backed by a group of successful entrepreneurs who have extensive experience in the areas of manufacturing, logistics, and renewable energy. It has secured a state-of-the-art agricultural facility in Leamington, Ontario – a preeminent locale for hemp cultivation in Canada.
FOR INFORMATION, CONTACT:
Sire Bioscience Inc.
The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.
Forward-Looking Information Cautionary Statement
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release. Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).